Addiction is characterized as a chronic debilitating disease. One devastating feature of addiction is the susceptibility of relapse (40 -60%) after stretches of abstinence. One theory that may account for relapse suggests that drug cues (e.g., paraphernalia) may increase stress hormones, and this may prompt relapse. Repeatedly pairing a neutral cue with a reward is commonly utilized to measure what subjects learn about a cue that is predictive of reward. Research has shown that animals that attend to a cue more than to the reward (sign trackers) may be more vulnerable to drug addiction. Additionally, research has shown that sign tracking is associated with an increase in corticosterone, a primary stress hormone. PT150 is a novel glucocorticoid receptor antagonist that moderates the release of corticosterone. In the current experiment, it was hypothesized that subjects given repeated administration of PT150 would reduce sign tracking compared to subjects given placebo. Time spent (in seconds) near a cue that predicts reward (conditional stimulus) served as a measure of sign tracking, and PT150 or placebo was administered following sign tracking. An independent-samples t test revealed that subjects that received PT150 had reduced time spent near the conditioned stimulus compared to controls. Given the devastating effects of drug addiction, identification of a potential pharmacological intervention in the reduction of relapse would be of great value. Therefore, future research is needed to validate the use of PT150 in reducing behaviors associated with drug addiction.
(goal trackers; GTs), the cue is equally predictive of reward (i.e., it serves as an effective CS), but they instead learn to approach the location of reward delivery, and for these rodents the CS is relatively ineffective as a conditioned reinforcer Yager & Robinson, 2010) .
The identification of animals that have the propensity to sign track is important because attribution of incentive salience to cues is associated with addictive behavior. In rats, STs that attribute incentive salience to a cue are more likely to self-administer cocaine compared to GTs (Beckmann, Marusich, Gipson, & Bardo, 2011) . Additionally, STs show greater cocaine-induced behavioral sensitization (Flagel, Watson, Akil, & Robinson, 2008) , a greater cocaine-induced conditioned place preference (Meyer, Ma, & Robinson, 2012) , and have more robust rates of reinstatement to drug-paired cues compared to GTs (Saunders & Robinson, 2010) . Overall, these studies show that STs may be more vulnerable to drug addiction.
In rodents, high levels of corticosterone (CORT), a predominant stress hormone, correlate with the propensity to sign track (e.g., Flagel et al., 2008) . Additionally, the presentation of a CS that predicts reward increases CORT (Tomie, Silberman, Williams, & Pohorecky, 2002; Tomie, Tirado, Yu, & Pohorecky, 2004 ) and this increase is greater in sign tracking rodents that attribute incentive salience to the cue (Flagel et al., 2008) . These findings suggest that CORT may be a potential target for reducing sign tracking behaviors.
It is widely accepted that visual cues in the environment may become associated with drug taking and subsequently, in the absence of drug, cause drug-seeking and ultimately relapse (Childress et al., 1999) . Therefore, studying substance abuse with an avian species may be of an additional benefit because birds are primarily visual whereas most rodents largely depend on olfaction (Carsia & Harvey, 2000; Crombag, Badiani, Maren, & Robinson, 2000) . Japanese quail are a visually oriented bird species with color vision and high visual acuity (Mills, Crawford, Domjan, & Faure, 1997) . Numerous drug studies have been conducted with Japanese quail (Akins & Geary, 2008; Bolin & Akins, 2012; Geary & Akins, 2007; Gill, Madison, & Akins, 2015; Gill, Rice, & Akins, 2015; Levens & Akins, 2004 ). These studies demonstrate that the drug responses in quail are largely conserved relative to rodents.
The hypothalamic-pituitary-adrenal (HPA) axis involves an auto-regulated feedback system that includes two types of adrenal steroid receptors, the glucocorticoid receptor (GR) and the mineralocorticoid receptor (MR; Bachmann, Linthorst, Holsboer, & Reul, 2003) . This dual receptor system is responsible for homeostasis of the HPA axis. GR antagonists (e.g., PT150) have been shown to increase MR expression (Bachmann et al., 2003) . When the MR/GR balance shifts toward an increase in MRs, there is a decreased CORT response to stress (de Kloet, 1991) . Therefore, PT150 may be a potential target for reducing the stress hormone CORT.
11, 21-Bisphenyl-19-norpregnane derivative (PT150) is a GR antagonist that competes with the binding of CORT in the cytoplasm (Peeters, Ruigt, Craighead, & Kitchener, 2008) . A similar compound to PT150 is RU486, which is a methylenedioxy phenyl analog of PT150 (Peeters et al., 2008) . However, in addition to competing with the GR, RU486 modulates the progesterone receptor (PR; Gagne, Pons, & Philibert, 1985) . The compound PT150 is a novel compound in that, unlike RU486, PT150 has minimal effect on the PR. PT150 has a 500-fold greater affinity for the GR, whereas RU 486 has a 5.4-fold affinity for the GR over the PR (Gebhard, Van Der Voort, Schuts, & Schoonen, 1997 ).
In the current study, we used a Pavlovian conditioning paradigm that measures individual differences in acquired incentive salience to cues that become associated with reward (Beckmann & Bardo, 2012; Domjan, Lyons, North, & Bruell, 1986; Flagel et al., 2008) . To assess the ability of a GR antagonist to attenuate sign tracking, PT150 was administered after acquisition of sign tracking in male quail. We hypothesized that PT150 would decrease sign tracking compared to placebo following repeated administration.
Method Subjects
Twenty-two adult male Japanese quail (Coturnix japonica) were hatched from eggs (Georgia Quail Farm, Savannah, GA) and were raised in mixed sex groups until approximately 6 weeks of age. Quail were housed in individual wire mesh cages (supplied by Georgia Quail Farm) and maintained on a 16:8-hr light cycle. At 10 months of age, 22 male quail were randomly assigned to one of two groups (drug or placebo; n ϭ 11 for both). The number of subjects per group was chosen based on a power analysis using Gpower (Erdfelder, Faul, & Buchner, 1996; Faul & Erdfelder, 1992) with power set at 0.80 and ␣ ϭ .05 for two-tailed F tests.
All experimental procedures were conducted according to the guidelines of the Institutional Animal Care and Use Committee at the University of Kentucky and by the standards outlined in the eighth edition of the Guide for the Care and Use of Laboratory Animals (National Research Council, 2010) . These entities adhere to the standards of the American Psychological Association ethical standards for treatment of animals.
Glucocorticoid Receptor Antagonist (PT150)
The study was designed to ensure that birds would voluntarily consume PT150 because forced administration (e.g., gavage in liquid vehicle) might have induced stress. Thus, a solid vehicle that birds found highly palatable, peanut butter (PB), was used to assure consumption of the drug. Use of highly palatable solid foods (e.g., PB and Nutella Ferrero SpA, Piedmont, Italy) are a common means of assuring voluntary oral consumption of pharmacological substances (Berger, Hancock, & deCatanzaro, 2007; Cope et al., 2005; Goldkuhl, Hau, & Abelson, 2010) .
Capsules containing drug (150 mg) or placebo were opened and added to PB (150 mg/2 g). The mixture was measured out at 0.53 mg/kg, resulting in a 40-mg/kg dose, and was given orally 1 hr before Pavlovian conditioning on Days 11-15. As a control measure, 0.53 mg/kg of PB was provided on Pavlovian conditioning Days 1-10. The dose of PT150 was chosen based on previous research with rodents (Sharrett-Field, 2013 ).
Apparatus
Behavioral testing was conducted in a standard conditioning chamber (Med Associates Inc., Georgia, VT; 22 cm ϫ 19 cm ϫ 13 cm) that had an acrylic hinged loading door, stainless steel side panels, and an acrylic back panel. The chamber was located in a sound-and lightThis document is copyrighted by the American Psychological Association or one of its allied publishers.
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attenuating cabinet equipped with a fan that provided continuous ventilation. A white noise generator provided low-level background noise, and a white house light provided illumination. Two keylights (red and green) were mounted at one end of the chamber 12.7 cm above the metal rod floor, and a food magazine (ENV-205m, Med Associates) was located between the keylights. The keylights and food magazine were illuminated with LED lights when activated.
Procedures
Food restriction. During Pavlovian conditioning, food restriction was used to ensure motivation of reward (i.e., grain). Male quail were maintained at 85% body weight, where food was available from 3 p.m. to 6 p.m. daily. This body weight matches previously defined avian methods of food deprivation (Duval, Cassey, Lovell, et al., 2013; Shousha, Nakahara, Nasu, Sakamoto, & Murakami, 2007) . Quail were weighed daily, and following the establishment of their mean free-feeding body weight, 18% of their mean body weight was calculated to provide minimum caloric intake in grams of feed to sustain 85% body weight throughout conditioning (e.g., Lejeune & Nagy, 1986) .
Conditioning. A Pavlovian-conditioned approach procedure was used to measure the attribution of incentive salience to a CS. Before conditioning, birds were shaped with successive approximation until they reliably retrieved grain from the hopper. Shaping was followed by 15 days of Pavlovian conditioning. During conditioning, each trial was composed of presentation of an 8-s green keylight (CSϩ) followed by immediate 8-s access to grain (unconditioned stimulus, US) in a food hopper. The pairing of the CS and US was on a variable time interval (VT) of 90 sec resulting in an average of a 30 min session. An 8-s red keylight (CSϪ) was presented unpaired with the US and used as a control, and thus was not predictive of food. Twenty trials were conducted each day for 15 days for a sum of 300 trials each for CSϩ and CSϪ. Time spent near the CS to both keylights was measured during CS presentation on Days 6, 10, 11, and 15. Day 6 was chosen because previous studies have shown that sign tracking is evident by Trial 125 of conditioning (e.g., Flagel et al., 2008) , which corresponds to Day 6 in the current experiment. Day 10 was the last day before PT150 was administered, Day 11 was the first day PT150 was administered, and Day 15 was the last day PT150 was administered.
Time spent near the CS was scored when subjects had both feet inside the zone (15.24 cm ϫ 7.62 cm) marked off in front of the CS light and were oriented toward the CS. Goal tracking was scored as time spent near the food hopper when subjects had both feet inside of the zone (15.24 cm ϫ 8.89 cm) marked off in front of the hopper. Video recordings were scored by visual observation. Researchers scoring the videos were blind to the treatment condition of the subjects.
Statistical Analysis
Sign and goal tracking. Repeated-measures analyses of variance (ANOVAs) were conducted with treatment as a betweensubjects factor and day (collapsed across trials) as a repeated measure to investigate changes in sign tracking to the CSϩ and the CSϪ. A repeated-measures ANOVA with treatment as a betweensubjects factor was conducted for Day 10 (the last day before treatment) and Day 15 (the last day of treatment) to determine the effects of repeated PT150 administration. A post hoc analysis was conducted on Day 15 to examine changes in sign tracking as a result of treatment. To determine the behavioral specificity of PT150, a repeated-measures ANOVA with treatment as a betweensubjects factor was conducted on goal tracking for Days 10 and 15.
Response bias. A response bias analysis was used to determine the relative amounts of sign and goal tracking and then to investigate whether drug effects were the same regardless of extent of sign tracking. A similar response bias analysis has been used in previous research (e.g., Paolone, Angelakos, Meyer, Robinson, & Sarter, 2013) To determine whether PT150 had a similar effect regardless of the extent of sign tracking, the relationship between the response bias and the difference score was analyzed with a Pearson's r correlation with treatment as a factor. For all statistical analyses, alpha was set at p Ͻ .05. Figure 1A shows mean sign tracking across days for each treatment group. A repeated-measures ANOVA revealed a main effect of day, F(3, 60) ϭ 12.25, p Ͻ .05, demonstrating that sign tracking (time spent at CSϩ) increased over conditioning days, regardless of treatment. There was no significant Day ϫ Treatment interaction, F(3, 60) ϭ 2.24, nor a main effect of treatment, F(1, 20) ϭ 2.6, ps Ͼ 0.05.
Results
The repeated-measures ANOVA conducted to investigate the effect of PT150 on sign tracking behavior revealed a Day ϫ To determine whether PT150 had an effect on time spent near the CSϪ, a repeated-measures ANOVA was conducted for Days 6, 10, 11, and 15 for placebo and drug treatments (see Figure 1B) . There was no significant Day ϫ Treatment interaction, F(3, 60) ϭ 2.13, indicating that treatment groups did not change in time spent This document is copyrighted by the American Psychological Association or one of its allied publishers.
near the CSϪ across days. There were also no main effects of treatment or day, Fs were between 0.38 to 2.13, ps Ͼ 0.05. To explore the individual differences of sign and goal tracking a response bias was calculated. The analysis showed that 12 out of 22 quail had a response bias toward sign tracking. Ten out of the 22 quail had neither a sign nor goal tracking response bias.
There was no positive correlation between the difference score and the response bias (r ϭ .52), nor between treatment groups and the response bias (r ϭ .06), ns ϭ 22, ps Ͼ 0.05. Therefore, the extent of sign tracking did not correlate with the difference score. However, there was a negative correlation between treatment groups and the difference score. Treatment with PT150 was correlated with decreased sign tracking, (r ϭ Ϫ0.47, p Ͻ .05). Thus, regardless of the extent of sign tracking, sign tracking appeared to be associated with treatment effects rather than the degree of the response bias.
To investigate the behavioral specificity of PT150, a repeatedmeasures ANOVA was conducted on Days 10 and 15 with goal tracking as the dependent variable. Results showed that there was no main effect of say, F(1, 20) ϭ 0.30, p Ͼ .05, indicating that time spent goal tracking did not change from Day 10 to 15. There was also no significant Day ϫ Treatment interaction, F(1, 20) ϭ 0.09, p Ͼ .05, indicating that the drug did not affect goal tracking. Overall, these results indicate that the behavioral effects of PT150 may have been specific to sign tracking.
Discussion
Similar to rodents, the quail in the current experiment demonstrated an increase in sign tracking toward a cue that had been paired with reward across days (e.g., Flagel et al., 2009 ). Most importantly, repeated oral consumption of PT150 resulted in a decrease in sign tracking behavior when compared to placebo. This reduction of sign tracking may have been the result of PT150 blocking the GR. Administration of the GR antagonist PT150 has been shown to reduce CORT in rodents that consumed alcohol (Reynolds et al., 2015) . This reduction in CORT was thought to occur because PT150 inhibits the nuclear translocation of the GR that indirectly regulates the release of CORT (Peeters et al., 2008) . Although the findings of the current experiment suggest that reduced sign tracking may have been a result of a blockade of the GR, it is unknown whether the GR is antagonized in the same manner in birds as in rodents.
There are changes in the brain that are related to sign tracking. For example, repeated activation of the reward pathway results in heightened behavioral responses that have been determined to be a predictor of drug addiction (Tomie, Grimes, & Pohorecky, 2008) . The HPA axis is involved in the activation and management of stress responses and has been shown to contribute to a heightened reward pathway (Piazza & Le Moal, 1998) . In Pavlovian conditioning, this heightened response (e.g., elevated pecking, sniffing, and licking) is often referred to as sign tracking (e.g., Tomie et al., 2008) . Similar to stress, sign tracking also disrupts the HPA axis and this may result in alteration of the HPA axis' negative feedback system, (e.g., Flagel et al., 2008; Tomie et al., 2008) . Therefore, in the current study, the reduction in sign tracking may have been associated with dysfunction of the HPA axis. The current study extends previous research by demonstrating reduced sign tracking as a result of repeated administration of a GR antagonist, suggesting that sign tracking may be associated with an increase in CORT and mediated via the GR.
The link between sign tracking and CORT is particularly interesting in that CORT could be a biomarker for future pharmacological treatments in individuals suffering from substance use disorders. However, further research is needed for validating the reduction of CORT by PT150 and its relationship to sign tracking. This article is intended solely for the personal use of the individual user and is not to be disseminated broadly.
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